Latest Insider Transactions at Intuitive Surgical Inc (ISRG)
This section provides a real-time view of insider transactions for Intuitive Surgical Inc (ISRG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTUITIVE SURGICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTUITIVE SURGICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 29
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
188
-3.3%
|
$74,448
$396.59 P/Share
|
|
May 29
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
188
+3.2%
|
$39,104
$208.9 P/Share
|
|
May 28
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
584
-3.41%
|
$235,936
$404.41 P/Share
|
|
May 28
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
584
+3.3%
|
$171,696
$294.45 P/Share
|
|
May 17
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
63
-17.6%
|
$24,948
$396.19 P/Share
|
|
May 17
2024
|
David J. Rosa President |
SELL
Bona fide gift
|
Direct |
2,507
-1.15%
|
-
|
|
May 16
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
175
-32.83%
|
$69,650
$398.28 P/Share
|
|
May 16
2024
|
Brian Edward Miller EVP & Chief Digital Officer |
SELL
Open market or private sale
|
Direct |
2,553
-20.97%
|
$1,021,200
$400.0 P/Share
|
|
May 15
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
175
-24.72%
|
$67,725
$387.22 P/Share
|
|
May 14
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
175
-19.82%
|
$66,500
$380.85 P/Share
|
|
May 13
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
175
-16.54%
|
$68,075
$389.16 P/Share
|
|
May 13
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
284
-2.48%
|
$110,476
$389.16 P/Share
|
|
May 13
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
90
+1.53%
|
$16,110
$179.7 P/Share
|
|
May 11
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
167
-2.85%
|
$64,462
$386.7 P/Share
|
|
May 11
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
360
+5.78%
|
-
|
|
May 10
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
239
-2.12%
|
$92,015
$385.55 P/Share
|
|
May 10
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
239
+2.08%
|
$63,813
$267.03 P/Share
|
|
May 03
2024
|
Mark J Rubash Director |
SELL
Open market or private sale
|
Direct |
1,709
-9.62%
|
$649,420
$380.0 P/Share
|
|
May 03
2024
|
Mark J Rubash Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,709
+8.78%
|
$504,155
$295.92 P/Share
|
|
Apr 29
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
376
-3.3%
|
$141,000
$375.39 P/Share
|
|
Apr 29
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
376
+3.2%
|
$93,624
$249.61 P/Share
|
|
Apr 26
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
1,498
-3.7%
|
$552,762
$369.09 P/Share
|
|
Apr 26
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
1,498
+3.53%
|
$386,484
$258.0 P/Share
|
|
Apr 25
2024
|
Mark J Rubash Director |
BUY
Exercise of conversion of derivative security
|
Direct |
569
+3.42%
|
-
|
|
Apr 25
2024
|
Jami K Nachtsheim Director |
BUY
Exercise of conversion of derivative security
|
Direct |
569
+9.18%
|
-
|
|
Apr 25
2024
|
Sreelakshmi Kolli Director |
BUY
Exercise of conversion of derivative security
|
Direct |
240
+50.0%
|
-
|
|
Apr 25
2024
|
Don R Kania Director |
BUY
Exercise of conversion of derivative security
|
Direct |
569
+12.91%
|
-
|
|
Apr 25
2024
|
Amal M Johnson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
569
+4.43%
|
-
|
|
Apr 25
2024
|
Amy L Ladd Director |
BUY
Exercise of conversion of derivative security
|
Direct |
569
+30.92%
|
-
|
|
Apr 25
2024
|
Keith R Leonard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
569
+26.16%
|
-
|
|
Apr 25
2024
|
Joseph C Beery Director |
BUY
Exercise of conversion of derivative security
|
Direct |
569
+19.35%
|
-
|
|
Apr 25
2024
|
Craig H Barratt Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
804
+2.98%
|
-
|
|
Apr 25
2024
|
Monica P Reed Director |
BUY
Exercise of conversion of derivative security
|
Direct |
569
+26.16%
|
-
|
|
Apr 25
2024
|
Alan J Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
569
+2.15%
|
-
|
|
Apr 23
2024
|
Alan J Levy Director |
SELL
Open market or private sale
|
Direct |
2,000
-7.32%
|
$740,000
$370.7 P/Share
|
|
Apr 23
2024
|
Alan J Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+6.82%
|
$308,000
$154.24 P/Share
|
|
Apr 23
2024
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,318
-89.89%
|
$1,967,660
$370.66 P/Share
|
|
Apr 23
2024
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,318
+47.34%
|
$957,240
$180.41 P/Share
|
|
Mar 15
2024
|
Fredrik Widman VP Corporate Controller |
SELL
Open market or private sale
|
Direct |
5,041
-88.91%
|
$2,001,277
$397.07 P/Share
|
|
Mar 15
2024
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,224
+45.88%
|
$72,216
$59.23 P/Share
|
|
Mar 11
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
329
-1.95%
|
$128,310
$390.16 P/Share
|
|
Mar 11
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
329
+1.91%
|
$77,973
$237.92 P/Share
|
|
Mar 11
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
196
-15.63%
|
$76,440
$390.16 P/Share
|
|
Mar 08
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
20,296
-14.54%
|
$7,976,328
$393.8 P/Share
|
|
Mar 08
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
14,728
+9.44%
|
$3,637,816
$247.37 P/Share
|
|
Mar 08
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
196
-13.52%
|
$76,832
$392.02 P/Share
|
|
Mar 07
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
196
-11.91%
|
$77,028
$393.3 P/Share
|
|
Mar 06
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
196
-10.64%
|
$75,656
$386.76 P/Share
|
|
Mar 05
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
196
-9.62%
|
$78,400
$400.0 P/Share
|
|
Mar 01
2024
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,605
-84.34%
|
$614,715
$383.48 P/Share
|